Obstacles, Opportunities, Biosimilars

Obstacles and Opportunities in Biosimilars

At the Biosimilar Drug Development World Europe event 2014,  Sophie Opdyke, Pfizer, gave a presentation on “Obstacles and Opportunities in Biosimilars” Download and learn: Obstacles Multiple Approaches To Clinical Development Interchangeability and Automatic Substitution Biosimilar Naming Download Presentation Found this interesting? Join us at next year’s Biosimilar Drug Development World Europe event happening this 4-5 March in Madrid.  The 4th annual Biosimilar …

IP, Pharma, Generics, Opportunities, Challenges, Europe,

IP in Pharma Generics Opportunities & Challenges in the EU

At the World Generic Medicines Congress Europe 2014, Thomas Kolzau, Helm AG, gave a presentation entitled “IP in Pharma Generics Opportunities & Challenges in the EU” Download and learn: Opportunities – pharma generics Challenges – pharma generics Oppositions in the generic market Appeals in the generic market Settlement Manufacturing & stockpiling Importance of the EU generics industry Impact of a manufacturing …

capitalizing, growth opportunities, complex generics, business models

Capitalizing On Growth Opportunities For Complex Generics To Strengthen Business Models

At the World Generic Medicines Congress Europe 2014, Dr Deepak Murpani, Synthon, gave the presentation “Capitalizing On Growth Opportunities For Complex Generics To Strengthen Business Models ” Download and learn: Why generics/ complex generics? Market trend What are complex generics? Case studies Summary Download presentation Found this interesting? Join us at the 9th annual World Generic Medicines Congress Europe, happening this 4-5 …

Keynote: New Pharma Partnering & Investment Opportunities

We’re at the final stretch of the conference with the remaining keynote session, “New Pharma Partnering & Investment Opportunities with Ajith Kamath, Wheaton Little and Younghwa Kim. Ajith Kamath, Senior Director and Head, Strategic Research Partnerships, Pfizer India spoke about the latest opportunities for strategic research partnerships in drug discovery by presenting drug discovery collaboration models at Pfizer. In an …

Download ebook: Top challenges and opportunities in generic medicines

  The benefits of generic medicines are well celebrated and they play an important role in treating disease by increasing the accessibility and affordability. Generics are a key contributor in securing sustainable health care systems but long term sustainability relies on fair price and a level playing field. In the current challenging market there are a number of hurdles to …

Challenges and opportunities in the treatment of rare diseases

Rare diseases affect more than 55 millions patients in US and EU alone, highlighting the huge societal impact of these diseases.  The various clinical, regulatory and commercial challenges to develop treatment for these diseases call for actions from various parties involved.  One of the successful initiatives is the orphan drug legislation by FDA in US.  Prior to the Orphan Drug …

Big pharma suffers as patents expire… but great opportunities for generics companies

As recently reported in the Nature News Blog, pharma companies are suffering as some of their best-selling products continue to fall off the "patent cliff". Astra Zeneca reported a 15% drop in revenue in Q3 of 2012, which was blamed primarily on expiring patents by the company's Chief Executive Pascal Soriot. Similarly, Sanofi reported that sales were down by 3.1% …

Top 5 ways Big Pharma is using Big Data

  The use of ‘Big Data’ is the latest, and possibly most powerful tool in a marketer’s arsenal, with more than 2.5 trillion pieces of data created worldwide each day. And according to PharmaTimes, In the healthcare arena, "data generation has gone crazy, driven by the increased use of electronic medical records, technological advances in genomic sequencing and monitoring devices, …